Sarcoma  >>  semaxanib (SU5416)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
semaxanib (SU5416) / Pfizer
NCT00002226: Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

Completed
N/A
30
US
SU5416
SUGEN
Sarcoma, Kaposi, HIV Infections
 
 

Download Options